Curcuminoids and ω-3 fatty acids with anti-oxidants potentiate cytotoxicity of natural killer cells against pancreatic ductal adenocarcinoma cells and inhibit interferon γ Production

Frontiers in Physiology

Volumn 6, Issue MAY, 2015, Pages

  Halder, Ramesh C ^a   Almasi, Anasheh ^a   Sagong, Bien ^a   Leung, Jessica ^a   Jewett, Anahid ^b,c   Fiala, Milan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA SCHOOL OF DENTISTRY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Curcumin; Interferon ; Natural killer cells; Pancreatic cancer; 3 fatty acids

Indexed keywords

CASPASE 3; CURCUMIN; CURCUMINOID; DOCOSAHEXAENOIC ACID; GAMMA INTERFERON; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 2; OMEGA 3 FATTY ACID; STAT1 PROTEIN; UNCLASSIFIED DRUG;

ADENOCARCINOMA CELL LINE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL ISOLATION; CELL PROTECTION; CONTROLLED STUDY; DRUG CYTOTOXICITY; EMULSION; ENZYME ASSAY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOFLUORESCENCE TEST; INCUBATION TIME; INTERFERON PRODUCTION; NATURAL KILLER CELL; OPTICAL DENSITY; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PROTEIN EXPRESSION;

EID: 84928906170     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2015.00129     Document Type: Article

References (20)

1. Aggarwal, S., Ichikawa, H., Takada, Y., Sandur, S. K., Shishodia, S., and Aggarwal, B. B. (2006). Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol. Pharmacol. 69, 195-206. doi: 10.1124/mol.105.017400.
2. American Cancer Society. (2012). Cancer Facts and Figures. Atlanta, GA: The Society.
3. Bill, M. A., Bakan, C., Benson, D. M. Jr, Fuchs, J., Young, G., and Lesinski, G. B. (2009). Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines. Mol. Cancer Ther. 8, 2726-2735. doi: 10.1158/1535-7163.MCT-09-0377.
4. Bill, M. A., Fuchs, J. R., Li, C., Yui, J., Bakan, C., Benson, D. M. Jr., et al. (2010). The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity. Mol. Cancer 9:165. doi: 10.1186/1476-4598-9-165.
5. Burris, H. A. III, Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M. R., et al. (1997). Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J. Clin. Oncol. 15, 2403-2413.
6. Chawla-Sarkar, M., Lindner, D. J., Liu, Y. F., Williams, B. R., Sen, G. C., Silverman, R. H., et al. (2003). Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8, 237-249. doi: 10.1023/A:1023668705040.
7. Gleissman, H., Yang, R., Martinod, K., Lindskog, M., Serhan, C. N., Johnsen, J. I., et al. (2010). Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates. FASEB J. 24, 906-915. doi: 10.1096/fj.09-137919.
8. Goel, A., Kunnumakkara, A. B., and Aggarwal, B. B. (2008). Curcumin as "Curecumin": from kitchen to clinic. Biochem. Pharmacol. 75, 787-809. doi: 10.1016/j.bcp.2007.08.016.
9. Greene, E. R., Huang, S., Serhan, C. N., and Panigrahy, D. (2011). Regulation of inflammation in cancer by eicosanoids. Prostaglandins Other Lipid Mediat. 96, 27-36. doi: 10.1016/j.prostaglandins.2011.08.004.
10. Gukovsky, I., Reyes, C. N., Vaquero, E. C., Gukovskaya, A. S., and Pandol, S. J. (2003). Curcumin ameliorates ethanol and nonethanol experimental pancreatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 284, G85-G95. doi: 10.1152/ajpgi.00138.2002.
11. Jewett, A., Man, Y. G., and Tseng, H. C. (2013). Dual functions of natural killer cells in selection and differentiation of stem cells; role in regulation of inflammation and regeneration of tissues. J. Cancer 4, 12-24. doi: 10.7150/jca.5519.
12. Kanai, M., Yoshimura, K., Asada, M., Imaizumi, A., Suzuki, C., Matsumoto, S., et al. (2011). A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother. Pharmacol. 68, 157-164. doi: 10.1007/s00280-010-1470-2.
13. Kim, K., Ryu, K., Ko, Y., and Park, C. (2005). Effects of nuclear factor-kappaB inhibitors and its implication on natural killer T-cell lymphoma cells. Br. J. Haematol. 131, 59-66. doi: 10.1111/j.1365-2141.2005.05720.x.
14. Lai, P., Rabinowich, H., Crowley-Nowick, P. A., Bell, M. C., Mantovani, G., and Whiteside, T. L. (1996). Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma. Clin. Cancer Res. 2, 161-173.
15. Maio, M., Altomonte, M., Tatake, R., Zeff, R. A., and Ferrone, S. (1991). Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene. J. Clin. Invest. 88, 282-289. doi: 10.1172/JCI115289.
16. Pestka, S., Krause, C. D., and Walter, M. R. (2004). Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202, 8-32. doi: 10.1111/j.0105-2896.2004.00204.x.
17. Sideras, K., Braat, H., Kwekkeboom, J., van Eijck, C. H., Peppelenbosch, M. P., Sleijfer, S., et al. (2013). Review: role of the immune system in pancreatic cancer progression and immune modulating treatment strategies. Cancer Treat. Rev. 40, 513-522. doi: 10.1016/j.ctrv.2013.11.005.
18. Tseng, H. C., Arasteh, A., Paranjpe, A., Teruel, A., Yang, W., Behel, A., et al. (2010). Increased lysis of stem cells but not their differentiated cells by natural killer cells; de-differentiation or reprogramming activates NK cells. PLoS ONE 5:e11590. doi: 10.1371/journal.pone.0011590.
19. Zaidi, M. R., and Merlino, G. (2011). The two faces of interferon-gamma in cancer. Clin. Cancer Res. 17, 6118-6124. doi: 10.1158/1078-0432.CCR-11-0482.
20. Zhang, H. G., Kim, H., Liu, C., Yu, S., Wang, J., Grizzle, W. E., et al. (2007). Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity. Biochim. Biophys. Acta 1773, 1116-1123. doi: 10.1016/j.bbamcr.2007.04.015.